trial · primary record
Amicidin-β topical solution - 15 mL
Surgical Wound Infection
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 44 |
| Primary completion | 2027-02-28 |
| Primary endpoint | Overall comparison of treatment emergent adverse events (TEAES) of combined SOC + Amicidin-β topical solution recipients to SOC only recipients across 3 cohorts. |
| Registry ID | NCT07379684 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:38.008Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07379684
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.